Live Chat

Beyond Bladder Cancer: The Other Risks of Actos

 Well-documented medical research and warnings from the Food and Drug Administration (FDA) have alerted thousands of Actos (pioglitazone) patients to the possibility that prolonged pioglitazone treatment may notably elevate their likelihood of developing bladder cancer. What many Actos patients don’t realize, however, is that their risks just start with bladder-related illnesses.

 

The side effects of Actos treatments extend to include heart problems, the possibility of bone fractures, and kidney failure as well. While prompt health care can address these issues, it often requires extended and expensive treatment. For many families, it’s important to find justice and to receive the help that their beloved family member needs.

 

The attorneys at the law firm of Fears Nachawati know how to help your loved one and your family recover from the surprising, frustrating, and painful side effects of Actos’s undisclosed risks. To learn how we may be able to assist you, contact us today at 1.866.545.8364 or email mn@fnlawfirm.com for your free consultation. 

Categories
Drug Litigation

Beyond Bladder Cancer: The Other Risks of Actos